Risk Scoring System Helps Predict Patient Nonadherence To Glaucoma Medication

Monday, August 12, 2013

Ocular Surgery News

A statistical risk assessment system was reliable in gauging the probability of patients’ noncompliance with glaucoma medication dosing instructions, according to a study.

Full Story

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

Smartphone-Based Retinal Screening System
D-EYE, The Modern Day Digital ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Risk Scoring System Helps Predict Patient Nonadherence To Glaucoma Medication

Comments

Quick Quiz

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?

AdGlare RMR Ad

Featured Products

Smartphone-Based Retinal Screening System

Selecta Trio™ YAG Laser, SLT and Photocoagulation

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2